Hisar Hospital Intercontinental
Hisar Hospital Intercontinental
Turkey, Istanbul
Mustafa Solak
20 years of experience
Clinic is certified :
Brachytherapy for prostate cancer in Turkey typically costs from $2,500 to $5,500. The final price depends on the radiotherapy technique, hospital accreditation, and the medical center's location. In the United States, patients pay around $20,000 on average for this treatment. Choosing Turkey offers savings of approximately 80%. Most treatment plans in Turkish oncology centers include the procedure, specialist consultations, and airport-to-clinic transfers.
Bookimed Expert Insight: Proximity to top-tier research pays off for patients at Anadolu Medical Center. Their affiliation with Johns Hopkins Medicine provides access to highly refined radioactive seed protocols. While packages at Hisar Hospital start around $3,900, the extra investment at Anadolu ensures JCI and OECI accredited care. This synergy between Turkish efficiency and American medical standards offers world-class oncology at a fraction of US prices.
Why choose Turkey for brachytherapy for prostate cancer?
Access advanced Brachytherapy for prostate cancer solutions in trusted clinics .
| Turkey | Austria | Spain | |
| Brachytherapy for prostate cancer | from $2,500 | from $9,000 | from $8,000 |
Day 1 - Arrival
Day 2 - Pre-Operation
Day 3 - Brachytherapy Procedure
Day 4 - Post-Operation
Week 1 - Rehabilitation
Week 2 - Rehabilitation
Week 4 - Rehabilitation
Week 6 - Rehabilitation
Please note that the timeline and procedure may vary according to individual patient conditions and clinic protocols.
Dr. Solak specializes in brachytherapy for prostate cancer at Hisar Hospital Intercontinental, with training from Hacettepe University Cancer Institute.
Dr. Alemdar specializes in brachytherapy for prostate cancer at Medical Park Antalya Hospital Complex, with extensive training in medical oncology.
Prof. Dr. Abdullah Sakin is a professor of medical oncology. He treats solid tumors, including lung, breast, gastrointestinal, genitourinary, gynecologic, head and neck cancers, and melanoma.
He delivers personalized, evidence-based care. His treatments include chemotherapy, targeted therapy, immunotherapy, hormone therapy, and precision oncology. He has authored more than 200 scientific publications and takes part in international clinical research. This work advances patient-centered cancer care.
Prof. Dr. Gül Alço is a radiation oncologist with about 27 years of experience. She treats breast, lung, prostate, gastrointestinal, gynecologic, central nervous system, head and neck, soft tissue, and bone cancers with radiotherapy.
Her expertise includes adaptive radiotherapy and radiosurgery. She uses advanced radiation techniques to provide personalized, evidence-based care in a multidisciplinary, patient-centered setting.
Written by Anna Leonova
Prostate brachytherapy in Turkey delivers success rates between 85% and 95%. It reaches 98% for early-stage localised cancer. These outcomes match international standards. Ten-year disease control rates exceed 90% in accredited centres. These centres use High-Dose Rate (HDR) and Low-Dose Rate (LDR) techniques.
Bookimed Expert Insight: Turkish oncology centres often offer HDR brachytherapy as a temporary implant. This can be safer for patients with urinary issues. Data shows that combined approaches at major hubs like Medipol Mega often result in lower recurrence than surgery. This is for intermediate-risk cases.
Patient Consensus: Success rates for localised cancer are excellent in Turkey. Many reports mention long-term control and low PSA levels. Patients appreciate the lower risk of incontinence compared to traditional surgery.
Leading Turkish oncologists hold prestigious international credentials for prostate brachytherapy. Many specialists complete fellowships at top-tier Western institutions like the University of Texas MD Anderson Cancer Center. They maintain active memberships in global bodies such as the European Society for Therapeutic Radiology and Oncology (ESTRO).
Bookimed Expert Insight: Turkish oncology centres like Anadolu Medical Center bridge the gap between local care and global standards. They do so through direct affiliations with US institutions. This partnership means treatment protocols for brachytherapy and similar therapies are aligned. They match those used in the world’s top cancer hospitals.
Patient Consensus: Patients in Turkey suggest verifying each doctor’s specific training pathway and hospital accreditation before booking. Experience shows that verifying JCI certification and Johns Hopkins affiliations provides the most confidence. This is especially important for prostate cancer treatments.
JCI-accredited oncology centres in Turkey primarily offer Low-Dose Rate (LDR) and High-Dose Rate (HDR) brachytherapy. These treatments use internal radiation to target localised prostate cancer. Leading facilities in Istanbul and Ankara use image guidance for precise placement while sparing healthy tissue.
Bookimed Expert Insight: While LDR seeds are traditional, major Turkish hubs like Anadolu Medical Center and Medipol Mega now favour HDR brachytherapy. HDR allows for more precise dose adjustments after the tubes are placed. This often results in better protection for the bladder and rectum compared to permanent seeds.
Patient Consensus: Patients in Turkey find that HDR is often completed in a single day under anaesthesia. The internal approach reduces typical radiation side effects, helping them return to light activities quickly.
Turkey hosts several Joint Commission International (JCI) accredited hospitals specialising in prostate brachytherapy. Leading centres like Anadolu Medical Center and Memorial Bahçelievler Hospital use precision technologies. These include 3T MRI and Elekta Versa HD radiotherapy. They deliver internal radiation that targets tumours while sparing healthy tissue.
Bookimed Expert Insight: Anadolu Medical Center holds both JCI and OECI accreditations. This rare combination signals adherence to strict European cancer institute standards. Their affiliation with Johns Hopkins gives Australian patients access to American-model oncology protocols at Turkish price points. These often start from $2,500.
Patient Consensus: Patients recommend focusing on large Istanbul systems like Memorial or Acıbadem. These have dedicated international departments. They suggest confirming the specific oncology specialist and asking for a written treatment plan in Turkey.